Christine F. Schubert
Munich, BY 81477, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma.
Journal: Frontiers in immunology
Published: October 26, 2023
Systemic immune response to a CD40 agonist antibody in nonhuman primates.
Journal: Journal of leukocyte biology
Published: March 22, 2023
MMP9 mRNA is a potential diagnostic and treatment monitoring marker for PTSD: Evidence from mice and humans.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: September 30, 2020
Oxytocin receptor is a potential biomarker of the hyporesponsive HPA axis subtype of PTSD and might be modulated by HPA axis reactivity traits in humans and mice.
Journal: Psychoneuroendocrinology
Published: September 17, 2020
Posttraumatic growth during cognitive behavioural therapy for posttraumatic stress disorder: Relationship to symptom change and introduction of significant other assessment.
Journal: Stress and health : journal of the International Society for the Investigation of Stress
Published: February 14, 2019
PTSD psychotherapy improves blood pressure but leaves HPA axis feedback sensitivity stable and unaffected: First evidence from a pre-post treatment study.
Journal: Psychoneuroendocrinology
Published: November 19, 2017
Posttraumatic Growth in Populations with Posttraumatic Stress Disorder-A Systematic Review on Growth-Related Psychological Constructs and Biological Variables.
Journal: Clinical psychology & psychotherapy
Published: February 02, 2015
Identification and characterization of HPA-axis reactivity endophenotypes in a cohort of female PTSD patients.
Journal: Psychoneuroendocrinology
Published: September 04, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026